(via TheNewswire)

CALGARY, AB – November 4, 2026 - TheNewswire – nDatalyze Corp. (CSE: NDAT) (OTC: NDATF) (the “Company” or “nDatalyze”) announces that the proposed reverse takeover transaction (the “RTO”) with Prism Diversified Ltd. (“Prism”) did not close on or before the October 31, 2026 completion deadline under the business combination agreement dated May 15, 2026 among the Company, Prism and 2273670 Alberta Ltd., as amended September 1, 2026 (the “Business Combination Agreement”), and no extension beyond October 31, 2026 was agreed to by the parties. The Company has delivered notice of termination of the Business Combination Agreement to Prism in accordance with its terms, and reserves all of its rights thereunder.

As the escrow release conditions under the concurrent subscription receipt financing were not satisfied prior to the escrow release deadline, the subscription proceeds held in escrow by Odyssey Trust Company will be returned to subscribers, and the subscription receipts will be cancelled, in each case in accordance with the terms of the subscription receipt agreement. No shares of the Company will be issued under the financing.

The spin-out transaction and name change approved by shareholders at the Company’s special meeting held on October 2, 2026 were conditional on completion of the RTO and will not be implemented at this time.

Trading in the Company’s common shares has been halted since the announcement of the proposed RTO. The Company will be applying to the CSE for reinstatement of trading, which remains subject to the review and approval of the CSE.

Jim Durward, President, states: “It’s unfortunate that the RTO did not close as set out in the Business Combination Agreement and First Amendment. This said, Epitome has always been the Company’s main asset and we intend to move forward with its commercialization, whether private or public. To this end, we will be presenting Epitome at Hockey Inspires Leadership Coach Day in Calgary on November 9, 2026.”

About nDatalyze Corp.

nDatalyze Corp. is a technology company focused on developing health and performance-related solutions through the application of advanced artificial intelligence and biometric data analytics, including the Epitome sports performance platform.

For Further Information, please contact:

Jim Durward, President, CEO/CTO

Email: jimd@ndatalyze.com

Tel: (403) 689-3901

nDatalyze Website: https://www.ndatalyze.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward-looking statements, including statements regarding the return of escrowed subscription proceeds, the reinstatement of trading of the Company’s common shares on the Canadian Securities Exchange and the commercialization of the Epitome platform. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward-looking statements. Although the Corporation believes that the expectations reflected in forward-looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.

Copyright (c) 2026 TheNewswire - All rights reserved.